| Name | Title | Contact Details |
|---|
Tru Grit set out to craft a line of professional grade fitness products for those who refuse to quit. Our passion for fitness and innovation inspires our team to create fitness equipment that are professional grade at an affordable price. Our products ...
Neptune Wellness is a publicly-held modern, (plant forward) CPG company driven by a singular purpose: to transform the everyday for a healthier tomorrow. Building upon our 20+ years of expertise in nutraceutical manufacturing and cannabis extraction, as well as a superior seed to shelf supply chain, we`re developing a suite of good-for-you, good-for-the-planet consumer brands across multiple verticals – including nutraceuticals, cannabis, personal care & beauty, food & beverage, and home. This transition to a fully integrated consumer packaged goods company enables Neptune to forge a new path in consumer health and wellness, with industry-changing implications.
Mobility Center Of Va is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Prior to Upward Health, Ward served as the Senior Vice President of Analytics at CareSource, a large health plan based in Ohio with multiple product lines in several states. Before CareSource, Ward held data and analytics leadership roles at a wide range of healthcare companies including Navvis, Corizon Health, naviHealth, and Centene. Ward brings to Upward Health a deep experience building prediction models, implementing business intelligence solutions, and driving process improvement through technology innovation.
Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.